LINK WILLIAM J PHD

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return -15% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
LINK WILLIAM J PHD's trades of Tarsus Pharmaceuticals, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-15
PlS Planned sale
41,626 +33.5%
402.17
US$2,529,077 		41,626 +33.5% 402.17 US$2,529,077
2026-06-17 2026-06-15
PlS Planned sale
79,621 -29.1%
66.66
US$4,938,703 		79,621 -29.1% 66.66 US$4,938,703
2026-06-15 2026-06-15
PrS Proposed sale
55,615
271.21
US$4,962,522 		55,615 271.21 US$4,962,522
2026-03-18 2026-03-16
PlS Planned sale
493 -0.4%
69.75
US$34,387 		493 -0.4% 69.75 US$34,387
2026-03-18 2026-03-16
PlS Planned sale
8,378 -6.7%
69.03
US$578,333 		8,378 -6.7% 69.03 US$578,333
2026-03-18 2026-03-16
PlS Planned sale
3,629 -2.8%
68.09
US$247,099 		3,629 -2.8% 68.09 US$247,099
2025-12-17 2025-12-15
PlS Planned sale
4,766 -100.0%
81.50
US$388,429 		4,766 -100.0% 81.50 US$388,429
2025-12-17 2025-12-15
PlS Planned sale
5,680 -54.4%
80.71
US$458,433 		5,680 -54.4% 80.71 US$458,433
2025-12-17 2025-12-15
PlS Planned sale
1,148 -0.9%
82.39
US$94,584 		1,148 -0.9% 82.39 US$94,584
2025-12-17 2025-12-15
PlS Planned sale
6,306 -4.6%
81.75
US$515,516 		6,306 -4.6% 81.75 US$515,516
2025-12-17 2025-12-15
PlS Planned sale
5,046 -3.6%
80.80
US$407,717 		5,046 -3.6% 80.80 US$407,717
2025-12-15 2025-12-15
PrS Proposed sale
10,446
81.02
US$846,340 		10,446 81.02 US$846,340
2025-12-15 2025-12-15
PrS Proposed sale
12,500
81.42
US$1,017,800 		12,500 81.42 US$1,017,800
2025-09-10 2025-09-08
S Sale
27,116 -15.9%
57.00
US$1,545,612 		27,116 -15.9% 57.00 US$1,545,612
2025-09-08 2025-09-08
PrS Proposed sale
27,116
57.01
US$1,546,000 		27,116 57.01 US$1,546,000
2024-08-14 2024-08-12
S Sale
5,021 -100.0%
26.53
US$133,207 		5,021 -100.0% 26.53 US$133,207
2024-08-14 2024-08-12
S Sale
29,979 -85.7%
26.01
US$779,754 		29,979 -85.7% 26.01 US$779,754
2024-02-02 2024-02-01
US Rxsight Inc (RXST)
S Sale
7,652 -24.0%
50.01
US$382,664 		7,652 -24.0% 50.01 US$382,664
2024-02-02 2024-02-01
US Rxsight Inc (RXST)
S Sale
20,598 -39.2%
49.54
US$1,020,456 		20,598 -39.2% 49.54 US$1,020,456
2024-02-01 2024-02-01
US Rxsight Inc (RXST)
PrS Proposed sale
28,250
49.59
US$1,401,000 		28,250 49.59 US$1,401,000
2021-10-20 2021-10-18
PlS Planned sale
1,531 -23.5%
15.09
US$23,109 		1,531 -23.5% 15.09 US$23,109
2021-10-20 2021-10-18
PlS Planned sale
1,912 -22.7%
14.63
US$27,978 		1,912 -22.7% 14.63 US$27,978
2021-10-20 2021-10-18
PlS Planned sale
242,943 -23.0%
15.09
US$3,666,957 		242,943 -23.0% 15.09 US$3,666,957
2021-10-20 2021-10-18
PlS Planned sale
303,614 -22.3%
14.63
US$4,442,693 		303,614 -22.3% 14.63 US$4,442,693
2020-12-03 2020-12-01
US Glaukos Corp (GKOS)
S Sale
600 -3.7%
68.72
US$41,232 		600 -3.7% 68.72 US$41,232
2020-12-03 2020-12-01
US Glaukos Corp (GKOS)
S Sale
49,400 -75.5%
67.96
US$3,357,091 		49,400 -75.5% 67.96 US$3,357,091